Modulatory and regenerative potential of transplanted bone marrow derived mesenchymal stem cells on rifampicin-induced kidney toxicity by Danjuma, Lawal et al.
Modulatory and regenerative potential of transplanted bone marrow derived 
mesenchymal stem cells on rifampicin-induced kidney toxicity 
ABSTRCT 
Anti-tuberculosis agent rifampicin is extensively used for its effectiveness. Possible 
complications of tuberculosis and prolonged rifampicin treatment include kidney damage; 
these conditions can lead to reduced efficiency of the affected kidney and consequently to 
other diseases. Bone marrow-derived mesenchymal stem cells (BMMSCs) can be used in 
conjunction with rifampicin to avert kidney damage; because of its regenerative and 
differentiating potentials into kidney cells. This research was designed to assess the 
modulatory and regenerative potentials of MSCs in averting kidney damage due to 
rifampicin-induced kidney toxicity in Wistar rats and their progenies. BMMSCs used in this 
research were characterized according to the guidelines of International Society for Cellular 
Therapy. 
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